60629-95-0

Basic information

• Product Name: 1-bromo-1-cyclopropylcyclopropane
• Synonyms: 1-bromo-1-cyclopropylcyclopropane;bromobi(cyclopropane);1-bromo-1,1-bi(cyclopropane)
• CAS NO: 60629-95-0
• Molecular Formula: C₆H₉Br
• Molecular Weight: 161.03966
• EINECS: -0
• Mol File: 60629-95-0.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 140 °C
• Appearance: /
• Density: 1.733±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 1-bromo-1-cyclopropylcyclopropane(CAS DataBase Reference)
• NIST Chemistry Reference: 1-bromo-1-cyclopropylcyclopropane(60629-95-0)
• EPA Substance Registry System: 1-bromo-1-cyclopropylcyclopropane(60629-95-0)

Safety Data

• Hazardous Substances Data: 60629-95-0(Hazardous Substances Data)

Usage

Physical state

Clear, colorless liquid

Solubility

Insoluble in water

Usage

Primarily used in organic synthesis and pharmaceutical research

Building block

For creating more complex molecules

Reactivity

High reactivity due to the presence of the bromine atom and the strained cyclopropane ring

Intermediate

Used in the production of various agrochemicals and pharmaceuticals

Unique structure

Valuable tool in the field of chemical and pharmaceutical research

Upstream product

• 54251-80-8 hydroxy-1 cyclopropyl-1 cyclopropane 
• 60629-94-9 Silber-1,1'-bicyclopropyl-1-carboxylat 

Downstream Products

• 151964-06-6 1,1'-Bicyclopropylidene-2-carboxylic acid 
• 1391837-72-1 (1-cyclopropylcyclopropyl)ethyne 
• 1391838-16-6 1-(1,1'-bicyclopropyl-1-yl)-2,3-bis(methoxymethyl)benzene 
• 1391838-13-3 [3-(1,1'-bicyclopropyl-1-yl)phenyl]trimethylsilane 
• 1236076-70-2 2-([1,1'-bi(cyclopropan)]-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 60629-92-7 1-cyclopropylcyclopropanecarboxylic acid 
• 27567-82-4 bicyclopropylidene 

Relevant articles and documents

Iron-Catalyzed Triazole-Enabled C-H Activation with Bicyclopropylidenes

C-H/C-C functionalizations with oxymethylated bicyclopropylidenes were accomplished with an iron catalyst under external oxidant-free conditions. The combination of the unique reactivity of bicyclopropylidenes with a robust iron(II) catalyst enabled C-C c

MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR

Compounds of Formula (I) pharmaceutically acceptable salts thereof, deuterated derivatives of any of the foregoing, and metabolites of any of the foregoing are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed. Also disclosed are solid state forms of Compound 1 and salts and solvates thereof.

A New General Approach to Bicyclopropylidenes

-